Valuation: Omnicell, Inc.

Capitalization 1.64B 1.38B 1.26B 1.2B 2.23B 148B 2.32B 14.64B 5.81B 71.64B 6.14B 6.02B 250B P/E ratio 2025
1,133x
P/E ratio 2026 * 88.7x
Enterprise value 1.64B 1.38B 1.26B 1.2B 2.23B 148B 2.32B 14.64B 5.81B 71.64B 6.14B 6.02B 250B EV / Sales 2025
1.72x
EV / Sales 2026 * 1.32x
Free-Float
80.46%
Yield 2025 *
-
Yield 2026 * -
1 day+0.88%
1 week-1.54%
Current month-24.74%
1 month-28.40%
3 months+3.93%
6 months+15.18%
Current year-19.43%
1 week 35.94
Extreme 35.94
39.46
1 month 35.38
Extreme 35.38
51.4
Current year 35.38
Extreme 35.38
55
1 year 22.66
Extreme 22.66
55
3 years 22.66
Extreme 22.66
77.14
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
Chief Tech/Sci/R&D Officer - 31/03/2025
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Change 5d. change 1-year change 3-years change Capi.($)
+0.88%-1.54%-7.85%-33.94% 1.64B
+1.23%-5.19%-25.59%-0.58% 28.62B
-1.06%-25.79%-58.75%+78.66% 8.73B
+4.63%+23.73% - - 5.36B
-0.36%-9.62%-29.84%+14.40% 3.92B
+6.13%-10.87% - - 2.11B
-8.14%-25.52% - - 1.76B
-1.53%+8.88%-23.26% - 1.37B
-1.62%+2.62%-18.93%-37.80% 1.23B
-0.97%+1.86%-38.81%+104.49% 832M
Average -0.08%-6.32%-29.00%+20.87% 5.56B
Weighted average by Cap. +0.80%-7.04%-31.56%+15.82%

Financials

2025 2026 *
Net sales 1.18B 998M 910M 869M 1.61B 107B 1.68B 10.58B 4.2B 51.78B 4.44B 4.35B 181B 1.24B 1.04B 953M 910M 1.69B 112B 1.75B 11.08B 4.4B 54.23B 4.65B 4.55B 190B
Net income 13.68M 11.53M 10.52M 10.04M 18.64M 1.24B 19.36M 122M 48.56M 599M 51.32M 50.26M 2.09B 18.63M 15.69M 14.32M 13.67M 25.37M 1.69B 26.36M 167M 66.1M 815M 69.85M 68.42M 2.85B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Employees
3,600
Date Price Change Volume
13/02/26 36.50 $ +0.88% 531,798
12/02/26 36.18 $ -4.34% 672,776
11/02/26 37.82 $ -3.03% 781,989
10/02/26 39.00 $ +6.85% 1,391,819
09/02/26 36.50 $ -1.54% 1,058,092
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
36.50USD
Average target price
57.43USD
Spread / Average Target
+57.34%

Quarterly revenue - Rate of surprise